Clinical Trial Update: Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 trial investigated simvastatin for secondary progressive multiple sclerosis; the study has completed and results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Imperial College London | Conditions: Secondary Progressive Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2019-12-12